These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


734 related items for PubMed ID: 30075764

  • 1. Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma.
    Pandit H, Li Y, Li X, Zhang W, Li S, Martin RCG.
    BMC Cancer; 2018 Aug 03; 18(1):783. PubMed ID: 30075764
    [Abstract] [Full Text] [Related]

  • 2. Shp2 promotes liver cancer stem cell expansion by augmenting β-catenin signaling and predicts chemotherapeutic response of patients.
    Xiang D, Cheng Z, Liu H, Wang X, Han T, Sun W, Li X, Yang W, Chen C, Xia M, Liu N, Yin S, Jin G, Lee T, Dong L, Hu H, Wang H, Ding J.
    Hepatology; 2017 May 03; 65(5):1566-1580. PubMed ID: 28059452
    [Abstract] [Full Text] [Related]

  • 3. Prolonged inhibition of class I PI3K promotes liver cancer stem cell expansion by augmenting SGK3/GSK-3β/β-catenin signalling.
    Liu F, Wu X, Jiang X, Qian Y, Gao J.
    J Exp Clin Cancer Res; 2018 Jun 25; 37(1):122. PubMed ID: 29940988
    [Abstract] [Full Text] [Related]

  • 4. The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer.
    Cai C, Zhu X.
    Mol Med Rep; 2012 May 25; 5(5):1191-6. PubMed ID: 22367735
    [Abstract] [Full Text] [Related]

  • 5. PTK2 promotes cancer stem cell traits in hepatocellular carcinoma by activating Wnt/β-catenin signaling.
    Fan Z, Duan J, Wang L, Xiao S, Li L, Yan X, Yao W, Wu L, Zhang S, Zhang Y, Li Y, Zhu X, Hu Y, Zhang D, Jiao S, Xu X.
    Cancer Lett; 2019 May 28; 450():132-143. PubMed ID: 30849480
    [Abstract] [Full Text] [Related]

  • 6. PAF enhances cancer stem cell properties via β-catenin signaling in hepatocellular carcinoma.
    Li M, Mu XD, Song JR, Zhai PT, Cheng Y, Le Y, Li ZB.
    Cell Cycle; 2021 May 28; 20(10):1010-1020. PubMed ID: 33970778
    [Abstract] [Full Text] [Related]

  • 7. Long non-coding RNA THOR promotes liver cancer stem cells expansion via β-catenin pathway.
    Cheng Z, Lei Z, Yang P, Si A, Xiang D, Zhou J, Hüser N.
    Gene; 2019 Feb 05; 684():95-103. PubMed ID: 30359743
    [Abstract] [Full Text] [Related]

  • 8. HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma.
    Lin X, Zuo S, Luo R, Li Y, Yu G, Zou Y, Zhou Y, Liu Z, Liu Y, Hu Y, Xie Y, Fang W, Liu Z.
    Theranostics; 2019 Feb 05; 9(25):7583-7598. PubMed ID: 31695788
    [Abstract] [Full Text] [Related]

  • 9. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX, Qi Y, Zhang J, Liu Y, Xu WH, Xu J, Hu HG, Wu QY, Wang Y, Zhang JP.
    Oncotarget; 2016 Nov 29; 7(48):79544-79556. PubMed ID: 27783993
    [Abstract] [Full Text] [Related]

  • 10. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
    Toh TB, Lim JJ, Hooi L, Rashid MBMA, Chow EK.
    J Hepatol; 2020 Jan 29; 72(1):104-118. PubMed ID: 31541681
    [Abstract] [Full Text] [Related]

  • 11. Downregulation of Cancer Stemness by Novel Diterpenoid Ovatodiolide Inhibits Hepatic Cancer Stem Cell-Like Traits by Repressing Wnt/[Formula: see text]-Catenin Signaling.
    Liu M, Bamodu OA, Kuo KT, Lee WH, Lin YK, Wu ATH, M H, Tzeng YM, Yeh CT, Tsai JT.
    Am J Chin Med; 2018 Jan 29; 46(4):891-910. PubMed ID: 29792038
    [Abstract] [Full Text] [Related]

  • 12. Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway.
    Li B, Cao Y, Meng G, Qian L, Xu T, Yan C, Luo O, Wang S, Wei J, Ding Y, Yu D.
    EBioMedicine; 2019 Jan 29; 39():239-254. PubMed ID: 30555042
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Growth differentiation factor 15 induces growth and metastasis of human liver cancer stem-like cells via AKT/GSK-3β/β-catenin signaling.
    Xu Q, Xu HX, Li JP, Wang S, Fu Z, Jia J, Wang L, Zhu ZF, Lu R, Yao Z.
    Oncotarget; 2017 Mar 07; 8(10):16972-16987. PubMed ID: 28199981
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Anticancer Effect of Polyphyllin I in Suppressing Stem Cell-Like Properties of Hepatocellular Carcinoma via the AKT/GSK-3β/β-Catenin Signaling Pathway.
    Liao M, Du H, Wang B, Huang J, Huang D, Tong G.
    Oxid Med Cell Longev; 2022 Mar 07; 2022():4031008. PubMed ID: 36317061
    [Abstract] [Full Text] [Related]

  • 17. High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma.
    Wei Y, Wang Y, Gong J, Rao L, Wu Z, Nie T, Shi D, Zhang L.
    Int J Oncol; 2018 Jan 07; 52(1):219-230. PubMed ID: 29138811
    [Abstract] [Full Text] [Related]

  • 18. Hepatic cancer stem cell marker granulin-epithelin precursor and β-catenin expression associate with recurrence in hepatocellular carcinoma.
    Cheung PF, Cheung TT, Yip CW, Ng LW, Fung SW, Lo CM, Fan ST, Cheung ST.
    Oncotarget; 2016 Apr 19; 7(16):21644-57. PubMed ID: 26942873
    [Abstract] [Full Text] [Related]

  • 19. Chitosan promotes cancer progression and stem cell properties in association with Wnt signaling in colon and hepatocellular carcinoma cells.
    Chang PH, Sekine K, Chao HM, Hsu SH, Chern E.
    Sci Rep; 2017 Apr 03; 8():45751. PubMed ID: 28367998
    [Abstract] [Full Text] [Related]

  • 20. Regulatory T cells inhibit FoxP3 to increase the population of tumor initiating cells in hepatocellular carcinoma.
    Liu C, Tu YJ, Cai HY, Pan YY, Wu YY, Zhang L.
    J Cancer Res Clin Oncol; 2024 Jul 29; 150(7):373. PubMed ID: 39073490
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 37.